Alert

Recommended Alerts

Sign Up For Alerts

Can They Really Do That? The Specter of Government-Authorized Infringement of Pharmaceutical Patents

The perception that pharmaceuticals in the United States are overpriced, and that patent rights are why, has been a recurrent political theme over the last several years. This view, along with the ongoing novel coronavirus pandemic, has caused some to consider whether the U.S. government should act to ensure affordable access to potentially life-saving medicines.

Read More

D.C. Circuit Holds That Former Purdue Pharma Executives Who Pleaded Guilty to Misdemeanor Misbranding May Be Excluded From Participation in Federal Health Care Programs

Practices: Life Sciences, Health Care, Government Enforcement / White Collar Criminal Defense

Printer-Friendly Version

Cookie Settings